epilepsy

A new anti-seizure target?

Vanderbilt neurologists have identified a protein modification that could be targeted to reduce neuronal excitability in epilepsy.

Pediatric neurologist Kevin Ess, MD, PhD, left, and pediatric neurosurgeon Robert Naftel, MD, follow up with patient Daniel Lookabaugh, who has epilepsy.

ROSA technology helps ease patient’s violent seizures

In the span of a month in December 2018, Daniel Lookabaugh suffered six severe seizures, requiring hospitalization at Monroe Carell Jr. Children’s Hospital at Vanderbilt each time to have neurological care as well as intervention from Pediatric Orthopaedics to reset his jaw and shoulder.

Brain image

Blueprint for treating epilepsy

Structural details of a protein that is essential to normal brain function could improve treatments for epilepsy and other seizure disorders.

epilepsy image

VIGH study seeks to expand epilepsy care efforts in Africa

The Vanderbilt Institute for Global Health (VIGH), with Aminu Kano Teaching Hospital (AKTH), will conduct a clinical trial in three cities in northern Nigeria to determine the efficacy of shifting childhood epilepsy care to epilepsy-trained community health extension workers.

Team discovers one more piece to the autism puzzle

Vanderbilt investigators have linked genetic mutations in a single receptor to epilepsy, autism and intellectual disability.

brain and lightning

Astrocytes and epilepsy

A protein with important functions in astrocytes — star-shaped brain support cells — may alter neuronal excitability and contribute to seizure activity, Vanderbilt researchers report.

1 2 3 4